Alexander Cumbo
Vorstandsvorsitzender bei SOLID BIOSCIENCES INC.
Vermögen: 148 929 $ am 30.04.2024
Aktive Positionen von Alexander Cumbo
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VERVE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 09.06.2022 | - |
Independent Dir/Board Member | 09.06.2022 | - | |
SOLID BIOSCIENCES INC. | Direktor/Vorstandsmitglied | 02.12.2022 | - |
Vorstandsvorsitzender | 02.12.2022 | - | |
Präsident | 02.12.2022 | - |
Karriereverlauf von Alexander Cumbo
Ehemalige bekannte Positionen von Alexander Cumbo
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | Direktor/Vorstandsmitglied | 01.10.2020 | 01.12.2022 |
Vorstandsvorsitzender | 01.10.2020 | 01.12.2022 | |
Präsident | 01.10.2020 | 01.12.2022 | |
SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2013 | 01.10.2020 |
RA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 14.11.2018 | 02.04.2020 |
Independent Dir/Board Member | 14.11.2018 | 02.04.2020 | |
Clinical Supplies Management, Inc.
Clinical Supplies Management, Inc. Medical/Nursing ServicesHealth Services Clinical Supplies Management, Inc. engages in the provision of clinical trial supply solutions for pharmaceutical and biotechnology companies. Its clinical services include packaging and labeling; storage and global distribution; chain management consulting; and returns, reconciliation, and destruction. The company was founded by Gerald E. Finken in 1997 and is headquartered in Fargo, ND. | Direktor/Vorstandsmitglied | 01.01.2012 | 01.01.2017 |
VERTEX PHARMACEUTICALS INCORPORATED | Vertrieb & Marketing | 01.06.2010 | 01.01.2013 |
Ausbildung von Alexander Cumbo
Auburn University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Operativ
Director/Board Member | 5 |
Independent Dir/Board Member | 2 |
Chief Executive Officer | 2 |
Sektoral
Health Technology | 7 |
Consumer Services | 2 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
SAREPTA THERAPEUTICS, INC. | Health Technology |
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
VERVE THERAPEUTICS, INC. | Health Technology |
SOLID BIOSCIENCES INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Ra Pharmaceuticals, Inc.
Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | Health Technology |
Clinical Supplies Management, Inc.
Clinical Supplies Management, Inc. Medical/Nursing ServicesHealth Services Clinical Supplies Management, Inc. engages in the provision of clinical trial supply solutions for pharmaceutical and biotechnology companies. Its clinical services include packaging and labeling; storage and global distribution; chain management consulting; and returns, reconciliation, and destruction. The company was founded by Gerald E. Finken in 1997 and is headquartered in Fargo, ND. | Health Services |
- Börse
- Insiders
- Alexander Cumbo
- Erfahrung